Search

Champions Oncology Inc

Gesloten

SectorGezondheidszorg

5.86 -1.68

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

5.6

Max

6.04

Belangrijke statistieken

By Trading Economics

Inkomsten

-514K

-278K

Verkoop

1.5M

17M

K/W

Sectorgemiddelde

35.118

62.58

EPS

-0.02

Winstmarge

-1.679

Werknemers

213

EBITDA

-508K

104K

Dividenden

By Acuity

Volgende Winsten

27 jul 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

1.8M

85M

Vorige openingsprijs

7.54

Vorige sluitingsprijs

5.86

Nieuwssentiment

By Acuity

21%

79%

41 / 340 Rangschikking in Healthcare

Champions Oncology Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

24 jul 2026, 20:06 UTC

Champions Oncology Inc shares are advancing, despite earlier intraday volatility. Broader market sentiment reflects easing inflation concerns amid significant oil price drops.

22 jul 2026, 19:41 UTC

Champions Oncology shares are declining during Wednesday's session, with no specific news identified. Broader market concerns are driven by rising crude oil prices.

Peer Vergelijking

Prijswijziging

Champions Oncology Inc Prognose

Beoordelingsconsensus

By TipRanks

0 ratings

0

Buy

0

Hold

0

Sell

Sentiment

By Acuity

41 / 340 Rangschikking in Gezondheidszorg

Nieuwssentiment

Zeer Sterk Bearish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Champions Oncology Inc

Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. In addition, it offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. The company markets its products through internet, word of mouth, and sales force to pharmaceutical and biotechnology companies. Champions Oncology, Inc. was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. The company was incorporated in 1985 and is headquartered in Hackensack, New Jersey.
help-icon Live chat